rabeprazole has been researched along with Anemia, Iron-Deficiency in 1 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
Anemia, Iron-Deficiency: Anemia characterized by decreased or absent iron stores, low serum iron concentration, low transferrin saturation, and low hemoglobin concentration or hematocrit value. The erythrocytes are hypochromic and microcytic and the iron binding capacity is increased.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 59-year-old man was orally administered rabeprazole, a proton pump inhibitor (PPI), for gastroesophageal reflux disease, after which he gradually developed iron-deficiency anemia." | 3.80 | Iron-deficiency anemia caused by a proton pump inhibitor. ( Chonan, A; Hashimoto, R; Matsuda, T, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, R | 1 |
| Matsuda, T | 1 |
| Chonan, A | 1 |
1 other study available for rabeprazole and Anemia, Iron-Deficiency
| Article | Year |
|---|---|
Iron-deficiency anemia caused by a proton pump inhibitor.
Topics: Anemia, Iron-Deficiency; Famotidine; Gastroesophageal Reflux; Humans; Male; Middle Aged; Proton Pump | 2014 |